ECCO Abstract Awards

Abstract submitters may participate in the application process for the following awards:

DOP Awards

One abstract of each digital oral presentation session has been nominated for this award by the chairs of the respective sessions.

The winners of the Top 10 DOP awards are:

DOP07: Chronic abdominal pain in IBD patients in remission: Real-world data on contributing factors - Ashkan Rezazadeh Ardabili, Maastricht, The Netherlands

DOP14: Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study - Richard James Michael Ingram, Alberta, Canada

DOP22: Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort study - Mohamed Attauabi, Hvidovre, Denmark

DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence model - Anthony Buisson, Clermont-Ferrand, France

DOP40: Impact of corticosteroid usage on efficacy and safety outcomes in patients receiving upadacitinib for Ulcerative Colitis - Timothy Raine, Cambridge, United Kingdom

DOP48: Hedgehog signalling controls Th17 differentiation to drive intestinal inflammation and is a druggable target for the treatment of IBD - Joachim Hanna, Cambridge, United Kingdom

DOP59: Development of a novel Ulcerative Colitis (UC) endoscopic activity prediction model using machine learning (ML) - David Rubin, Chicago, United States

DOP69: Long-term outcome of infantile and very early onset IBD: A multi-center study from the IBD Porto group of ESPGHAN - Anat Guz Mark, Petah Tikva, Israel

DOP78: Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD) - María José García, Santander, Spain

DOP89: Infliximab and ustekinumab clearance during induction predicts post-induction endoscopic outcomes in patients with Crohn’s Disease - Zhigang Wang, Leuven, Belgium

Top 10 DOP Award 2022 Anat Guz Mark (Israel)

Top 10 DOP Award 2022 Anthony Buisson (France)

Top 10 DOP Award 2022 Ashkan Rezazadeh Ardabili (The Netherlands)

Top 10 DOP Award 2022 David Rubin (United States)

Top 10 DOP Award 2022 Joachim Hanna (United Kingdom)

Top 10 DOP Award 2022 María José García (Spain)

Top 10 DOP Award 2022 Mohamed Attauabi (Denmark)

Top 10 DOP Award 2022 Richard Ingram (Canada)

Top 10 DOP Award 2022 Timothy Raine (United Kingdom)

Top 10 DOP Award 2022 Zhigang Wang (Belgium)

Best Investigator-Initiated Study (IIS) report submitted - IIS Abstract Award

The Clinical Research Committee of ECCO (ClinCom) wants to stimulate the development of high-quality Investigator-Initiated Studies (IIS) in IBD and to improve the quality of IBD clinical studies in Europe through education. In 2022, awards will be given to the 2 best congress abstracts reporting on clinical studies set up by investigators (preferably multi-centre) submitted for the ECCO Congress. Note: Studies conducted by industry will not be eligible for this award.

Responsible Committee: Clinical Research Committee of ECCO (ClinCom)
Prize: Free registration for the ECCO Congress 2023
Number of awards: 2
Who can apply: ECCO Members reporting on clinical studies set up by investigators in their abstracts. Note: ECCO Membership fee 2022 must be paid up until the abstract submission deadline.
How to apply:

In case you are not an ECCO Member yet please register for ECCO Membership 2022
Log in to the ECCO'22 Abstract submission system
At the beginning of the submission process please indicate if your abstract is qualified for the IIS Abstract Award
Please pay careful attention to the general guidelines for abstract submission
Upload your abstract for the ECCO Congress 2022
Notification of the author in the beginning of December 2021
Announcement at the ECCO'22 Congress

IIS Award 2022 Dan Turner (Israel)

IIS Award 2022 Edouard Louis (Belgium)

Y-ECCO Abstract Award

The Young ECCO (Y-ECCO) encourages Y-ECCO Members to submit their abstract and share their research with the ECCO Community. Awards will be given to the 5 best-ranked abstracts along with a free congress registration for the following year.

Responsible Committee: Young-ECCO (Y-ECCO)
Prize: Free registration for the ECCO Congress 2023
Number of awards: 5
Who can apply: Y-ECCO Members (below 35 years of age or still in training). Note: ECCO Membership fee 2022 must be paid up until the abstract submission deadline.
How to apply:

In case you are not an ECCO Member yet please register for ECCO Membership 2022
Log in to the ECCO'22 Abstract submission system
At the beginning of the submission process please indicate if your abstract is qualified for the Y-ECCO Abstract Award
Please pay careful attention to the general guidelines for abstract submission
Upload your abstract for the ECCO Congress 2022
Notification of the author in the beginning of December 2021
Announcement at the ECCO'22 Congress